December 09, 2009 08:30 ET

ONE Bio Launches Beauty and Therapeutic Treatment Product Line

MIAMI, FL--(Marketwire - December 9, 2009) - ONE Bio, Corp. ("ONE" or the "Company") (OTCBB: ONBI), an innovative company utilizing green process manufacturing to produce raw chemicals and herbal extracts, natural and health supplements and organic products, announced that its chemical and herbal extract division ("CHE") officially launched its "Complete Beauty and Treatment Series" over-the-counter product line.

This complete series of therapeutic products has been developed to target salons and nutrition retail locations. The state of the art product formulations have been developed, prepared and tested by some of the industries top nutritional experts and cosmeticians.

The product line was officially launched at the 5th Cross-strait Forestry Expo and Fair for Investment and Trade. The show focused on "Developing Green Industries," and was recently held in the Sanming Exhibition Center in Sanming City, China where more than 80,000 people and companies from 15 countries attended the event.

The Complete Beauty Treatment Series includes:

Whitening Series:
 -- Whitening treatment for freckles and blemishes

Moisturizing Series:
 -- Moisture treatment for hydration

Rejuvenating Series:
 -- Revitalizing treatment for wrinkles and fine lines

Oil-Controlling Series:
 -- Therapeutic treatment for acne and blackheads

Eye Care Series:
 -- Retina treatment for anti-aging

Estrogen Therapeutic Series:
 -- Regulates estrogen for breast care and ovarian treatment

Energy Supplement:
 -- Physiotherapy treatment for blood shortage and cervical pressure

Slimming Series:
 -- Body treatment for slimming and contouring

"The launch of end users over-the-counter products in our chemical and herbal extracts division is a very important step for ONE Bio's strategy to further increase the vertical integration of our product portfolio. To date the CHE division has focused exclusively on wholesaling raw materials. Now, in addition to wholesale, we have the ability to increase market penetration with end-user products which is a very profitable, high margin segment of the marketplace," stated ONE's CEO Marius Silvasan. "The initial response to our products has been overwhelmingly positive which helps validate our marketing strategy. As we focus our product development efforts we're determined to concentrate our efforts in areas where we anticipate strong demand in the near future throughout the Asia Pacific region," added Silvasan.

About ONE Bio, Corp.

ONE Bio, Corp. ("ONE") (OTCBB: ONBI) ( headquartered in Miami, FL, is an innovative company utilizing green process manufacturing to produce raw chemicals and herbal extracts, natural supplements and organic products. ONE is focused on the Asia Pacific region. Key products include widely recognized Solanesol, CoQ10, Resveratrol and 5-HTP, organic fertilizers, and organic bamboo health food and beverages. ONE's growth plan targets an aggressive acquisition driven strategy supported by strong organic growth. Through ONE, small private companies gain access to capital, experienced management and strategic insight. ONE builds strong synergies amongst all subsidiaries to enhance shareholder value. ONE is working with each subsidiary to promote organic and acquisition driven growth.

This press release includes statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). ONE Bio, Corp. claims the protection of the safe-harbor for forward-looking statements contained in the Reform Act. These forward-looking statements are often characterized by the terms "may," "believes," "projects," "expects," or "anticipates," and do not reflect historical facts. Specific forward-looking statements contained in this press release include, but are not limited to: our successful integration of diversified growth companies, impact of the company's expansion plan, and new business development success, future financial results, development and acquisition of new product lines and services, the impact of competitive products or pricing from technological changes, the effect of economic conditions and other uncertainties. The forward-looking statements contained herein involve risks and uncertainties that could cause actual results to differ materially from the expectations contained in any such forward-looking statements. These risks include, but are not limited to: failure to manage operating expenses or integrate new companies and/or technologies, each of which could have a material impact on our business, our financial results, and the company's stock price. These risks and other factors are detailed in the Company's regular filings with the U.S. Securities and Exchange Commission. Most of these factors are difficult to predict accurately and are generally beyond the Company's control. Forward-looking statements speak only as to the date they are made and ONE Bio, Corp. does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

Contact Information